BMJ gastroenterology COVID-19 collection
This collection of articles highlights all research relating to the COVID-19 pandemic published by Gut, Frontline Gastroenterology and BMJ Open Gastroenterology. It will continue to grow as new articles are published online.
In the current climate, it is vital that research into the disease is as accessible as possible for clinicians, healthcare workers and researchers across the globe. We hope that this collection of research into COVID-19 and gastroenterology will be a useful resource.
To explore more research, news, opinion pieces and resources published by The BMJ and all BMJ Journals, visit BMJ’s Coronavirus Hub where all COVID-19 content is free to view. For the latest updates on research published by the journals and guidance from the British Society of Gastroenterology, be sure to follow @Gut_BMJ, @FrontGastro_BMJ , @BMJOpen_Gastro and @BritSocGastro on Twitter.
Jump to:
COVID-19 Clinical
COVID-19 IBD
COVID-19 Endoscopy
COVID-19 Basic Science
COVID-19 Epidemiology
COVID-19 GI Service
COVID-19 Hepatology
COVID-19 Clinical
Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus
Gut, 26th February 2020, Letter
SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19
Gut, 5th February 2020, Letter
COVID-19 in gastroenterology: a clinical perspective
Gut, 20th March 2020, Letter
COVID-19 and the gastrointestinal tract: more than meets the eye
Gut, 9th April 2020, Commentary
Gastrointestinal Symptoms of 95 Cases with SARS-CoV-2 Infection
Gut, 2nd April 2020, Original Research
Faecal calprotectin indicates intestinal inflammation in COVID-19
Gut, 20th April 2020, Letter
COVID-19 and the gastrointestinal tract: emerging clinical data
Frontline Gastroenterology, 27th April 2020, Review
Severe liver failure during SARS-CoV-2 infection
Gut, 23rd April 2020, Letter
COVID-19 guidance in chronic diseases: a need to reach across the borders of the traditional medical specialities
Frontline Gastroenterology, 7th May 2020, Letter
GI symptoms as early signs of COVID-19 in hospitalised Italian patients
Gut, 14th May 2020, Letter
The price of being a doctor during the COVID-19 outbreak
Gut, 10th May 2020, Letter
Comparative study of the clinical characteristics and epidemiological trend of 244 COVID-19 infected children with or without GI symptoms
Gut, 19th May 2020, Letter
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study
Gut, 20th May 2020, Letter
Novelty in the gut: a systematic review and meta-analysis of the gastrointestinal manifestations of COVID-19
BMJ Open Gastroenterology, 25th May 2020, Gastrointestinal Infection
Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California
Gut, 3rd June 2020, Letter
Pneumatosis intestinalis in COVID-19
BMJ Open Gastroenterology, 9th June 2020, Case Report
Risk factors in patients with COVID-19 developing severe liver injury during hospitalisation
Gut, 22nd June 2020, Letter
GI symptoms and fever increase the risk of severe illness and death in patients with COVID-19
Gut, 30th June 2020, Letter
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic
Gut, 3rd July 2020, Guidelines
Alteration of taste or smell as a predictor of COVID-19
Gut, 3rd July 2020, Letter
COVID-19 and the gastrointestinal tract: recent data
Frontline Gastroenterology, 5th July 2020, Education
Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19
Gut, 20th July 2020, Original Research
Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
Gut, 30th July 2020, Gastroduodenal
Gastrointestinal manifestations of COVID-19 in children: a systematic review and meta-analysis
Frontline Gastroenterology, 18th August 2020, Education
A nationwide cohort study with propensity score matching
Gut, 9th October 2020, Letter
Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study
Gut, 4th December 2020, Letter
Proton pump inhibitors and the risk of severe COVID-19: a post-hoc analysis from the Korean nationwide cohort
Gut, 10th December 2020, Letter
Aerosol generation and droplet spread during nasogastric intubation in the COVID-19 era
Gut, 31st December 2020, Letter
Serotonin is elevated in COVID-19-associated diarrhoea
Gut, 5th January 2021, Letter
Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19
Gut, 2nd June 2021, Letter
Duality of the association between COVID-19 and acute pancreatitis
Gut, 3rd June 2021, Letter
Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic?
Gut, 17th June 2021, Letter
Identification of the source events for aerosol generation during oesophago-gastro-duodenoscopy
Gut, 29th June 2021, Original Research
The value of anal swab RT-PCR for COVID-19 diagnosis in adult Indonesian patients
BMJ Open Gastroenterology, 19th May 2021, Infection
COVID-19 IBD
A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis
Gut, 3rd March 2020, Letter
An urgent need to institute COVID-19 testing in patients with IBD experiencing flares
Frontline Gastroenterology, 27th March 2020, Opinion
Covid-19 and immunomodulation in IBD
Gut, 17th April 2020, Recent advances in basic science
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Gut, 17th April 2020, Guidelines
Covid-19 infection in Crohn’s disease under treatment with adalimumab
Gut, 20th April 2020, Letter
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study
Gut, 30th April 2020, Original Research
Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel
Gut, 8th June 2020, Original Research
Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic
Frontline Gastroenterology, 16th June 2020, Original Research
Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds
Gut, 17th June 2020, Letter
Implications of recurrent SARS-CoV-2 outbreaks for IBD management
Frontline Gastroenterology, 24th June 2020, Review
Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel
Gut, 1st September 2020, Original Article
COVID-19-related health anxieties and impact of specific interventions in patients with inflammatory bowel disease in the UK
Frontline Gastroenterology, 11th September 2020, Original Research
Effect of IBD medications on COVID-19 outcomes: results from an international registry
Gut, 20th October 2020, Original Research
Disease monitoring of biologic treatment in IBD: early impact and future implications of COVID-19 pandemic
Frontline Gastroenterology, 30th September 2020, Opinion
Life in lockdown: experiences of patients with IBD during COVID-19
BMJ Open Gastroenterology, 19th November 2020, IBD
COVID-19 and IBD drugs: should we change anything at the moment?
Gut, 19th November 2020, Commentary
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic
Gut, 12th February 2021, Letter
Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national survey
BMJ Open Gastroenterology, 12th February 2021, IBD
COVID-19: impetus to the adoption of capsule endoscopy as a primary diagnostic tool?
Frontline Gastroenterology, 24th February 2021, Commentary
Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?
Gut, 3rd March 2021, Letter
Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System
Gut, 22nd March 2021, Original Research
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
Gut, 7th April 2021, Original Research
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
Gut, 26th April 2021, Original Research
Point-of-care faecal calprotectin testing in patients with paediatric inflammatory bowel disease during the COVID-19 pandemic
BMJ Open Gastroenterology, 4th May 2021, IBD
COVID-19 Endoscopy
Practice of Endoscopy during COVID-19 Pandemic: Position Statements of Asian Pacific Society of Digestive Endoscopy (APSDE-COVID Statements)
Gut, 2nd April 2020, Guidelines
The prevention of nosocomial SARS-CoV2 transmission in endoscopy: international recommendations and the need for a gold standard.
Gut, 2nd April 2020, Letter
Gastrointestinal endoscopy during COVID-19: when less is more
Frontline Gastroenterology, 15th April 2020, Commentary
Low risk of covid-19 transmission in GI endoscopy
Gut, 22nd April 2020, Endoscopy News
APSDE-COVID statements: recommendations should be modified according to the prevalence of COVID infection rates
Gut, 30th April 2020, Letter
Safely restarting GI endoscopy in the era of COVID-19
Gut, 5th June 2020, Leading Article
Impact of the COVID-19 outbreak on endoscopy training in a tertiary care centre in Germany
Frontline Gastroenterology, 10th June 2020, Education
COVID-19 and endoscopy training
Frontline Gastroenterology, 10th June 2020, Letter
Development and evaluation of a novel protective device for upper gastrointestinal endoscopy in the COVID-19 pandemic: the EBOX
Frontline Gastroenterology, 12th June 2020, Original Research
Data from a large Western centre exploring the impact of COVID-19 pandemic on endoscopy services and cancer diagnosis
Frontline Gastroenterology, 20th July 2020, Original Research
Protective enclosure for performing gastrointestinal endoscopy
Frontline Gastroenterology, 4th August 2020, Letter
Multicentre prospective study of COVID-19 transmission following outpatient GI endoscopy in the UK
Gut, 14th September 2020, Endoscopy News
Effects of SARS-CoV-2 emergency measures on high-risk lesions detection: a multicentre cross-sectional study
Gut, 28th September 2020, Endoscopy News
Clinical, financial and academic implications of COVID-19 on a tertiary care interventional endoscopy programme
Gut, 14th December 2020, Endoscopy News
Endoscopes used in positive and critically ill patients are SARS-CoV-2 negative at virological assessment
Gut, 6th January 2021, Endoscopy News
Adherence to recommendations for endoscopy practice during COVID-19 pandemic in Latin America: how are we doing it?
BMJ Open Gastroenterology, 12th January 2021, Endoscopy
Endoscopy training in the UK pre-COVID–19 environment: a multidisciplinary survey of endoscopy training and the experience of reciprocal feedback
Frontline Gastroenterology, 7th February 2021, Original Research
SARS-CoV-2 transmission via endoscopy in the COVID-19 era
Gut, 5th March 2021, Letter
COVID-19 transmission following outpatient endoscopy during pandemic acceleration phase involving SARS-CoV-2 VOC 202012/01 variant in UK
Gut, 24th March 2021, Endoscopy News
SARS-CoV-2 in endoscopy: a potential way of microorganisms’ air transmission
Gut, 5th May 2021, Letter
COVID-19 Basic Science
Digestive system is a potential route of COVID-19: an analysis of single-cell co-expression pattern of key proteins in viral entry process
Gut, 2nd April 2020, Original Research
Alterations in the human oral and gut microbiomes and lipidomics in COVID-19
Gut, 31st March 2021, Original Research
Enhanced donor screening for faecal microbial transplantation during COVID-19
Gut, 31st March 2021, Letter
Six-month follow-up of gut microbiota richness in patients with COVID-19
Gut, 8th April 2021, Letter
Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19
Gut, 26th April 2021, Leading Article
COVID-19 Epidemiology
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms
Gut, 23rd March 2020, Original Research
Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series
Gut, 4th June 2020, Gastroduodenal
Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis
BMJ Open Gastroenterology, 4th March 2021, Epidemiology
COVID-19 GI Service
Gastroenterology department operational reorganisation at the time of covid-19 outbreak: an Italian and Chinese experience
Gut, 16th April 2020, Leading Article
Gastrointestinal cancer pathways may breakdown due to COVID-19
Frontline Gastroenterology, 11th June 2020, Letter
Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis
Gut, 20th July 2020, Original Research
Clinical research during the COVID-19 pandemic: gastroenterology researchers’ perspective
Frontline Gastroenterology, 29th July 2020, Opinion
Recovery of endoscopy services in the era of COVID-19: recommendations from an international Delphi consensus
Gut, 14th August 2020, Guidelines
COVID-19 and its impact on endoscopy services: what is the threshold for missed malignant diagnosis?
Gut, 26th August 2020, Letter
Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study
Gut, 27th August 2020, Original Research
Triage guidance for upper gastrointestinal physiology investigations during restoration of services during the COVID-19 pandemic
Frontline Gastroenterology, 30th September 2020, Opinion
Exit strategies from the COVID-19 lockdown for children and young people receiving home parenteral nutrition (HPN): lessons from the BSPGHAN Intestinal Failure Working Group experience
Frontline Gastroenterology, 27th October 2020, Opinion
Mandatory preprocedure testing for SARS-CoV-2 for all-comers may not be required for resuming endoscopic services amidst the ongoing COVID-19 pandemic
Gut, 6th November 2020, Letter
Impact of COVID-19 pandemic on key performance indicators in pancreatobiliary endoscopy: prioritise, minimise risk, keep scoping and training
Frontline Gastroenterology, 15th December 2020, Original Research
COVID-19 and endoscopic services: the impact of delays in therapeutic colonoscopies on patients
Gut, 4th February 2021, Letter
Gastroenterology 2021: from the heart of the COVID-19 pandemic
Frontline Gastroenterology, 5th February 2021, Opinion
COVID-19 Hepatology
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis
Gut, 15th May 2020, Letter
Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis
Gut, 25th May 2020, Leading Article
One world, one pandemic, many guidelines: management of liver diseases during COVID-19
Gut, 4th June, Leading Article
COVID-19 in an international European liver transplant recipient cohort
Gut, 22nd June 2020, Original Research
Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19
Gut, 8th July 2020, Original Research
Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort
Gut, 13th July 2020, Original Research
Involvement of liver in COVID-19: systematic review and meta-analysis
Gut, 15th July 2020, Letter
Liver stiffness by transient elastography accompanies illness severity in COVID-19
BMJ Open Gastroenterology, 13th July 2020, Hepatology
Modulating immunosuppression in liver transplant patients with COVID-19
Gut, 18th August 2020, Letter
COVID-19 in patients with cirrhosis: understanding adverse impact
Gut, 21st August 2020, Letter
Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19
Gut, 7th October 2020, Letter
Severe alcohol-related liver disease admissions post-COVID-19 lockdown: canary in the coal mine?
Frontline Gastroenterology, 26th October 2020, Letter
Abnormal liver blood tests among hospitalised patients with SARS-CoV2 (COVID-19)
Frontline Gastroenterology, 2nd November 2020, Commentary
Liver dysfunction in COVID-19: a useful prognostic marker of severe disease?
Frontline Gastroenterology, 22nd December 2020, Original Research
Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study
Gut, 29th January 2021, Original Research
Liver injury, hypoalbuminaemia and severe SARS-CoV-2 infection
Gut, 2nd June 2021, Letter
Exercising in the COVID-19 era: implications in non-alcoholic fatty liver disease (NAFLD)
BMJ Open Gastroenterology, 24th June, Communication